Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications

Study of Visceral Fat in Type 2diabetic Patients and Its Relation to Microvascular Complications

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06112197

Enrollment

100

Registered

2023-11-01

Start date

2024-01-05

Completion date

2025-06-05

Last updated

2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Visceral Fat

Brief summary

Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

Detailed description

The Metabolic Score for Insulin Resistance (METS-IR) is a metabolic index developed with the aim to quantify peripheral insulin sensitivity in humans; it was first described under the name METS-IR by Bello-Chavolla et al in 2018. It was developed by the Metabolic Research Disease Unit at the Institute National de Ciencias Médicas Salvador Zubirán and validated against the euglycemic hyperinsulinemic clamp and the frequently-sampled intravenous glucose tolerance test in Mexican population.It is a non-insulin-based alternative to insulin-based methods to quantify peripheral insulin sensitivity and an alternative to the Homeostatic Model Assessment (HOMA-IR) and the quantitative insulin sensitivity check index (QUICKI). Very limited research correlate between visceral obesity and microvascular complications in type 2 diabetic patients and how can the metabolic score for insulin resistance predict visceral obesity and microvascular complications in type2 diabetic patients. In this study the investigators will search for these correlations.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Age \> 18 years Both male and female subjects Subjects capable of giving consent and voluntarily willing to participate in the study

Exclusion criteria

* Chronic kidney disease patients Any nondiabetic nephropathy patients Patients affected by hypertension Patients affected by ocular disorders Neuropathies of other etiologies like chronic liver disease patients, alcoholics, or drug addicts Critically ill patients of type 2 diabetes mellitus Patients who have not given consent

Design outcomes

Primary

Measure	Time frame	Description
correlation between METS IR and visceral fat in type 2 diabetes	one year	Study the cor relation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

Countries

Egypt

Outcome results